metricas
covid
Buscar en
Atención Primaria
Toda la web
Inicio Atención Primaria Knowledge, attitude, and practice towards COVID-19: Research to develop a measur...
Información de la revista
Vol. 54. Núm. 8.
(agosto 2022)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Visitas
3045
Vol. 54. Núm. 8.
(agosto 2022)
Original article
Open Access
Knowledge, attitude, and practice towards COVID-19: Research to develop a measuring instrument
Conocimiento, actitud y práctica frente a la COVID-19: Investigación para desarrollar un instrumento de medición
Visitas
3045
Olgun Göktaşa,
Autor para correspondencia
olgun_goktas@hotmail.com

Corresponding author.
, Canan Ersoyb
a Bursa Uludağ University Family Health Center, Nilüfer, Bursa, Turkey
b Bursa Uludağ University Faculty of Medicine, Department of Internal Medicine, Division of Endocrinology and Metabolism, Nilüfer, Bursa, Turkey
Este artículo ha recibido

Under a Creative Commons license
Información del artículo
Resumen
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Figuras (3)
Mostrar másMostrar menos
Abstract
Objective

To evaluate the knowledge, attitudes, and behaviors of individuals about COVID-19 and to develop a valid and reliable scale that can measure these items about COVID-19 and other similar pandemic processes.

Design

Methodological scale study with a quantitative approach.

Site

Carried out at the Uludağ University Family Health Center in Bursa, Turkey.

Participants

415 individuals in the first phase and 367 in the retest phase.

Interventions

Carried out between March 1, 2021, and April 30, 2021.

Main measurements

Reliability and factor analyses were performed and validity was evaluated. In factor analysis, a scale with 4 factors and 30 questions was obtained. Confirmatory factor analysis (CFA) was applied to the factor scores of the scale. Factors were named A-General Culture, B-Mask, Distance and Cleanliness, C-Mental Status, and D-Way of Information. A 3-point Likert-type scoring system was created for the responses.

Results

Cronbach's alpha value was 0.894. In factor modeling, 3 of the confirmatory factor analysis fit indices were good and 4 of them were acceptable, so our model was found to be appropriate. The scale was highly reliable, according to internal and external consistency coefficients. The scale was named the Turkey COVID-19 Attitude Scale. p values<0.05 were considered statistically significant.

Conclusions

The valid and reliable Turkey COVID-19 Attitude Scale, which we developed to evaluate the knowledge, attitudes, and behaviors of individuals about COVID-19, can be used to guide research during COVID-19 and future pandemics.

Keywords:
Knowledge
Attitude
Practice
COVID-19
Turkey-scale
Resumen
Objetivo

Evaluar los conocimientos, actitudes y comportamientos de los individuos sobre la COVID-19 y desarrollar una escala válida y confiable para medir estos ítems sobre la COVID-19 y otros procesos pandémicos similares.

Diseño

Estudio de escala metodológica con enfoque cuantitativo.

Emplazamiento

Centro de Salud Familiar de la Universidad de Uludağ, en Bursa, Turquía.

Participantes

415 individuos en la primera fase y 367 en la fase de retest.

Intervenciones

Realizadas entre el 1 de marzo de 2021 y el 30 de abril de 2021.

Mediciones principales

Análisis de confiabilidad y factoriales para evaluar la validez. Se obtuvo una escala con cuatro factores y 30 preguntas. Se aplicó el análisis factorial confirmatorio (AFC) a las puntuaciones de la escala. Los factores se denominaron A-Cultura general, B-Máscara, distancia y limpieza, C-Estado mental y D-Vía de información. Para las respuestas se creó un sistema de puntuación tipo Likert de tres puntos.

Resultados

El valor alfa de Cronbach fue de 0,894. Tres de los índices de ajuste del análisis factorial confirmatorio fueron buenos y cuatro de ellos aceptables, por lo que se consideró el modelo como apropiado. La escala resultó altamente confiable, según los coeficientes de consistencia interna y externa. Se denominó Escala de Actitud de Turquía COVID-19. Los valores de p < 0,05 se consideraron estadísticamente significativos.

Conclusiones

La Escala de Actitud de Turquía COVID-19 válida y confiable, desarrollada para evaluar el conocimiento, las actitudes y los comportamientos de las personas sobre COVID-19, se puede utilizar para guiar la investigación durante COVID-19 y futuras pandemias.

Palabras clave:
Conocimiento
Actitud
Práctica
COVID-19
Escala Turquía
Texto completo
Introduction

The World Health Organization (WHO) declared the novel coronavirus (2019-nCoV) pandemic to be an international public health emergency in 2020.1 The influenza A (H1N1) pandemic in 2009 was also an important public health issue and provided important experience for managing future pandemics. The COVID-19 pandemic has shown the importance of obtaining information about new diseases, making decisions in the face of deficiencies and difficulties, providing an attitude, and taking action.2 Individual knowledge and attitude are as important as social measures in epidemic management.3,4

To increase attitudes and behaviors among the public, health officials and policymakers should promote belief in knowledge and effectiveness. Future interventions and policies should be developed in a person-centered approach to COVID-19 and targeting vulnerable subgroups.5 Despite the increase in COVID-19 cases, providing adequate information with educational interventions can reduce negative attitudes. Correlations between knowledge, attitudes and practices are important in preventing infection.6–12

A systematic review of the general population showed that the components of knowledge, attitude, and practice (KAP) towards COVID-19 were at an acceptable level. Using an integrated international system can help to better evaluate these components and compare them across countries.13

The current pandemic highlights the importance of education level in the formation of adequate knowledge, attitudes, and practices, and the importance of providing valid, effective, efficient and continuous information to the public through appropriate channels to increase understanding of COVID-19 measures.14–16

The aim of this study was to evaluate the knowledge, attitudes, and practices of individuals about COVID-19 and to develop a valid and reliable scale that can guide measurement in COVID-19 and other pandemics.

MethodsStudy design and setting

In this study, 415 individuals who applied to Bursa Uludağ University Family Health Center completed a questionnaire between March 1, 2021, and April 30, 2021. In the retest phase, 367 participants completed the questionnaire. The opinions of 10 specialist doctors were obtained to determined the validity of the 42 items on the questionnaire, in terms of content and scope, prior to participants completing the questionnaire. Based on their feedback, 12 questions were excluded from the question pool because the content validity ratio (CVR) remained below the lower limit of 0.62. The content validity ratio of the remaining questions was 0.91. Reliability and factor analyses for the questions were performed, and their validity was evaluated. In factor analysis, a scale with 4 factors and 30 questions was obtained. Factor analysis was used to determine the factor scores of the scale. Factors were named A-General Culture, B-Mask, Distance and Cleanliness, C-Mental Status, and D-Way of Information. A 3-point Likert-type scoring system was created for the responses (1-Agree, 2-No idea, 3-Disagree). Participants were asked about sociodemographic information in the questionnaire, and they were asked to mark the fit option under the attitude statements.

Number of samples

The number of population for this study was 518382, and it was calculated as a total of 415 people, using P=0.5 to maximize the number of samples to be taken, at 95% confidence level, with a sampling error of 5%, 400 people+15 people as spares. Sample Calculation was done using the following formula.

n: Number of Samples

N: Number of Population

d: Effect Size (calculated with a 5% margin of error)

P: probability of occurrence of X event (0.5 taken for maximum number of samples)

Q: Probability of not seeing event X (1P)

/2: Standard normal distribution value

Randomization and sample size calculation (Fig. 1).17

Figure 1.

Sample calculation.

(0.03MB).

Sequence numbers were assigned to patients registered in our Family Health Unit who met the study criteria. Then, random numbers will be generated between 1 and **ni (i. Number of people who meet the inclusion criteria registered in the family health center) by using the (RAND*(ba)+a) function in excel. Randomization was achieved by taking the patients with row numbers opposite to these generated numbers into the study.

In terms of sample size calculation, individuals who applied to our Family Health Center during the study period, were literate, and had no cognitive adjustment or vision problems were included in the study

Ethics

The study received approval from the Republic of Turkey Ministry of Health (Ref. 2021-02-16T16-37-09), and the Clinical Research Ethics Committee of Bursa, Uludağ University, Faculty of Medicine (Ref. 2011-KAEK-26), following the Declaration of Helsinki.

Statistical analysis

SPSS 26.0 and AMOS 22.0 (IBM Corporation, Armonk, New York, United States) programs were used in the analysis of the variables. Spearman's rho test was used to examine the correlations of the variables with each other. In the question pool created for the validity of the research, the opinions of 10 experts for 42 questions were taken and the questions were eliminated according to the content validity indices, and content validity was performed. The smallest content validity index was 0.62 and questions below this rate were not included in the study. 5 questions were excluded because they were below the minimum coverage validity of 0.62. The content validity index of the final questions is 0.91. Afterwards, 50 questionnaires were applied for the pilot study. According to the results of the analysis obtained, 7 questions with low reliability were removed and the study was continued with 30 questions. Re-test for reproducibility from reliability analyzes, Cronbach's Alpha coefficient for consistency and item factor correlations were calculated. Explanatory Factor analyzes were applied for factor constructions. Confirmatory factor analysis from structural equation modeling was applied to confirm the factor structures obtained, and model validity was determined by fit indices. Quantitative variables were expressed as mean (standard deviation), and Median (Minimum/Maximum) and in the tables, while categorical variables were shown as n (%). The variables were analyzed at 95% confidence level, and a p value less than 0.05 was considered significant.

Results

In the first stage of the study, 415 people completed the questionnaire; 367 people participated in the retest stage which occurred at least 1 week later. Question 27 was the reverse question. The average scoring of the test questions varied between 2.20 and a maximum of 2.93 (Table 1).

Table 1.

Test questions and scoring.

No  Questions  Disagree  No idea  Agree 
    1 point  2 points  3 points 
COVID-19 stands for Coronavirus disease 2019       
COVID-19 is caused by the SARS-CoV-2 virus       
The SARS-CoV-2 virus that causes COVID-19 was first identified in 2019 in Wuhan, China       
SARS-CoV-2 virus is transmitted from person to person       
COVID-19 can occur in all age groups       
The main symptoms of COVID-19 are fever, cough, difficulty breathing, chills, muscle pain, headache, sore throat, loss of taste and smell       
COVID-19 causes pneumonia in some patients       
COVID-19 causes no symptoms or signs in some people       
Those who have COVID-19 without symptoms can also transmit the virus to other people       
10  COVID-19 may have a more severe course in people with diseases such as diabetes, obesity, asthma, heart disease, cancer       
11  Symptoms often begin after 4-5 days in a person infected with the SARS-CoV-2 virus, but can last up to 14 days       
12  SARS-CoV-2 virus may show mutation (change)       
13  People who have had COVID-19 can be tested to see if they have developed antibodies to the SARS-CoV-2 virus       
14  Social distancing, mask use, and washing hands with soap and water are very important in protection from COVID-19       
15  It is necessary to be at least 1.5-2 meters away for social (-physical) distance to provide protection from COVID-19       
16  When using a mask, the mouth and nose must be covered to protect against COVID-19       
17  To prevent COVID-19, the face, eyes, mouth and nose should not be touched without proper washing of hands       
18  If I have come into contact with a person who is positive for COVID-19, I apply to the health institution by following the mask, distance, and hygiene rules       
19  Vaccination is very important in preventing COVID-19       
20  People who have been vaccinated for protection from COVID-19 should also continue to follow the rules of social distancing, use of masks, and washing hands with soap and water       
21  I feel stressed due to COVID-19       
22  I am having trouble sleeping due to COVID-19       
23  I have been away from my family, friends and social circle due to COVID-19       
24  I obtained my information about COVID-19 from written and visual media       
25  I got my information about COVID-19 by researching it on the internet       
26  I obtained my knowledge about COVID-19 by researching scientific medical literature       
27  I have never researched COVID-19, I am informed by what I hear from my environment       
28  I follow all the rules, including mask, distance, hygiene, to protect from COVID-19       
29  I take vitamin supplements to protect myself from COVID-19       
30  I take herbal supplements to protect myself from COVID-19       

In the factor analysis, it was determined that the sample size was sufficient and that there was a suitability in providing the relationship between the variables. After factor subtraction, the existing 4 factors explain approximately 76% of the variance (Table 2 and Fig. 2).

Table 2.

Explained variance and eigenvalues of factors.

Item  Initial  Extraction (variance explained when subtracted)  Components  Eigenvalues  % of explained variance  Cumulative % of total variance explained 
Item 1  0.628  1  11.265  37.551/34.130*  37.551/34.130* 
Item 2  0.569  2  5.971  19.902/20.639*  57.453/54.769* 
Item 3  0.655  3  3.276  10.920/11.755*  68.373/66.525* 
Item 4  0.709  4  2.344  7.813/9.662*  76.187/76.187* 
Item 5  0.810  5  0.891  2.969  79.155 
Item 6  0.840  6  0.739  2.464  81.619 
Item 7  0.752  7  0.618  2.059  83.679 
Item 8  0.677  8  0.500  1.668  85.346 
Item 9  0.879  9  0.453  1.509  86.855 
Item 10  0.817  10  0.408  1.359  88.215 
Item 11  0.871  11  0.387  1.290  89.505 
Item 12  0.873  12  0.310  1.035  90.540 
Item 13  0.772  13  0.291  0.971  91.511 
Item 14  0.852  14  0.262  0.872  92.383 
Item 15  0.862  15  0.250  0.835  93.218 
Item 16  0.851  16  0.228  0.761  93.979 
Item 17  0.955  17  0.202  0.675  94.654 
Item 18  0.911  18  0.199  0.663  95.317 
Item 19  0.816  19  0.176  0.586  95.903 
Item 20  0.851  20  0.168  0.560  96.464 
Item 21  0.622  21  0.155  0.517  96.981 
Item 22  0.720  22  0.147  0.491  97.472 
Item 23  0.521  23  0.141  0.468  97.940 
Item 24  0.665  24  0.135  0.451  98.392 
Item 25  0.826  25  0.127  0.423  98.814 
Item 26  0.443  26  0.103  0.344  99.158 
Item 27  0.689  27  0.093  0.311  99.469 
Item 28  0.870  28  0.073  0.244  99.713 
Item 29  0.798  29  0.044  0.145  99.858 
Item 30  0.753  30  0.042  0.142  100.000 
KMO and Bartlett's Test:  0.933
Bartlett's Test of Sphericity  p<0.001

Extraction method: principal component analysis.

*

After rotation.

KMO: Kasier–Meyer–Olkin Test.

Figure 2.

The first line break.

(0.16MB).

In the factor analysis, the correlation coefficients were determined to be suitable for the factors. Since the first break was at the fourth point in the factor loads, SPSS and scree plots, 4 factors were decided (Table 3).

Table 3.

Factor loadings, eigenvalues and variance explained.

Component  Component matrixa  Rotated component matrixb
  Factor loadings  Factor loadings  Eigenvalues of factors  Variance explained by factors 
Factor 111.265  34.130 
Item 1  0.774  0.780     
Item 2  0.747  0.715     
Item 3  0.801  0.778     
Item 4  0.824  0.822     
Item 5  0.885  0.880     
Item 6  0.886  0.907     
Item 7  0.846  0.853     
Item 8  0.812  0.792     
Item 9  0.923  0.918     
Item 10  0.886  0.888     
Item 11  0.909  0.918     
Item 12  0.925  0.904     
Item 13  0.862  0.856     
Item 19  0.920  0.953     
Factor 25.971  20.64 
Item 14  0.882  0.883     
Item 15  0.894  0.921     
Item 16  0.899  0.927     
Item 17  0.888  0.919     
Item 18  0.938  0.974     
Item 20  0.891  0.922     
Item 28  0.851  0.903     
Factor 33.276  11.76 
Item 21  0.883  0.927     
Item 22  0.761  0.786     
Item 23  0.825  0.847     
Item 29  0.566  0.634     
Item 30  0.779  0.825     
Factor 42.344  9.66 
Item 24  0.666  0.706     
Item 25  0.871  0.893     
Item 26  0.831  0.864     
Item 27  0.773  0.812     

Extraction method: principal component analysis.

a

4 components extracted.

b

Rotation converged in 4 iterations.

The Cronbach's alpha value was determined to be 0.894. It was at a good level in terms of internal consistency and was close to perfect (Table 4).

Table 4.

Cronbach's alpha values of the factors.

  GeneralSplit – half Cronbach's alpha 
Component  Cronbach's alpha when items are deleted  Total item correlation  Cronbach's alpha value of factors  Part 1–Part 2 
Factor 10.974  0.936–0.964 
Item 1  0.762  0.974     
Item 2  0.720  0.975     
Item 3  0.782  0.973     
Item 4  0.815  0.973     
Item 5  0.879  0.972     
Item 6  0.892  0.971     
Item 7  0.840  0.972     
Item 8  0.792  0.973     
Item 9  0.920  0.971     
Item 10  0.877  0.972     
Item 11  0.913  0.971     
Item 12  0.921  0.971     
Item 13  0.858  0.972     
Item 19  0.883  0.972     
Factor 20.976  0.960–0.946 
Item 14  0.895  0.974     
Item 15  0.901  0.973     
Item 16  0.893  0.974     
Item 17  0.966  0.969     
Item 18  0.936  0.971     
Item 20  0.893  0.974     
Item 28  0.906  0.973     
Factor 30.881  0.837–0.849 
Item 21  0.661  0.868     
Item 22  0.751  0.848     
Item 23  0.584  0.885     
Item 29  0.824  0.828     
Item 30  0.781  0.839     
Factor 40.818  0.820–0.774 
Item 24  0.606  0.843     
Item 25  0.763  0.765     
Item 26  0.476  0.838     
Item 27  0.649  0.816     
General  0.894  0.955–0.813  0.894  0.955–0.813 

Reliability test.

The factor coefficient, which is one of the related questions for Factor 1, ranges from 0.150 to 0.065 (Table 5).

Table 5.

Coefficients of factor scores.

Component score coefficient matrix
  Component
  Factor 1  Factor 2  Factor 3  Factor 4 
Item 1  0.082  −0.002  0.000  −0.029 
Item 2  0.065  −0.002  0.017  0.013 
Item 3  0.075  0.001  0.019  −0.010 
Item 4  0.082  −0.009  −0.001  −0.004 
Item 5  0.089  −0.003  −0.009  −0.006 
Item 6  0.097  −0.009  −0.007  −0.034 
Item 7  0.088  −0.005  −0.016  −0.012 
Item 8  0.077  0.003  −0.021  0.015 
Item 9  0.094  0.002  −0.013  −0.013 
Item 10  0.092  −0.001  −0.012  −0.019 
Item 11  0.095  −0.009  −0.015  −0.011 
Item 12  0.088  0.001  0.006  −0.004 
Item 13  0.085  −0.008  −0.001  −0.001 
Item 19  0.150  −0.015  0.002  0.007 
Item 14  −0.010  0.088  −0.012  0.002 
Item 15  −0.009  0.152  −0.010  −0.005 
Item 16  −0.012  0.150  −0.002  0.007 
Item 17  −0.012  0.159  0.010  −0.001 
Item 18  −0.009  0.156  0.000  −0.009 
Item 20  −0.008  0.152  0.005  −0.019 
Item 28  −0.003  0.151  0.003  −0.016 
Item 21  −0.025  0.003  0.232  −0.002 
Item 22  −0.028  −0.007  0.253  −0.013 
Item 23  −0.013  0.005  0.205  −0.001 
Item 29  −0.030  0.000  0.266  −0.013 
Item 30  −0.024  0.002  0.255  −0.010 
Item 24  −0.062  −0.015  0.005  0.326 
Item 25  −0.062  −0.020  −0.002  0.359 
Item 26  −0.030  0.003  −0.014  0.242 
Item 27  −0.053  −0.011  −0.025  0.328 

Extraction method: principal component analysis. Rotation method: equamax with Kaiser normalization.

Correlation coefficients were high in the test and retest relationships, indicating that they were correlated. The results showed that reliability was reproducible in terms of internal and external consistency (Table 6).

Table 6.

Test and retest correlation coefficients.

(n=367)  r  p 
Question 1 & Retest – Question 1  0.967  <0.001 
Question 2 & Retest – Question 2  0.975  <0.001 
Question 3 & Retest – Question 3  0.965  <0.001 
Question 4 & Retest – Question 4  0.968  <0.001 
Question 5 & Retest – Question 5  0.909  <0.001 
Question 6 & Retest – Question 6  0.923  <0.001 
Question 7 & Retest – Question 7  0.941  <0.001 
Question 8 & Retest – Question 8  0.919  <0.001 
Question 9 & Retest – Question 9  0.928  <0.001 
Question 10 & Retest – Question 10  0.930  <0.001 
Question 11 & Retest – Question 11  0.927  <0.001 
Question 12 & Retest – Question 12  0.910  <0.001 
Question 13 & Retest – Question 13  0.938  <0.001 
Question 14 & Retest – Question 14  0.881  <0.001 
Question 15 & Retest – Question 15  0.877  <0.001 
Question 16 & Retest – Question 16  0.884  <0.001 
Question 17 & Retest – Question 17  0.867  <0.001 
Question 18 & Retest – Question 18  0.874  <0.001 
Question 19 & Retest – Question 19  0.932  <0.001 
Question 20 & Retest – Question 20  0.877  <0.001 
Question 21 & Retest – Question 21  0.954  <0.001 
Question 22 & Retest – Question 22  0.978  <0.001 
Question 23 & Retest – Question 23  0.954  <0.001 
Question 24 & Retest – Question 24  0.977  <0.001 
Question 25 & Retest – Question 25  0.960  <0.001 
Question 26 & Retest – Question 26  0.966  <0.001 
Question 27 & Retest – Question 27  0.960  <0.001 
Question 28 & Retest – Question 28  0.872  <0.001 
Question 29 & Retest – Question 29  0.971  <0.001 
Question 30 & Retest – Question 30  0.987  <0.001 

Paired samples correlations.

r: correlation coefficient.

In confirmatory factor analysis, Factor 1 ranged between 0.80 and 0.98, Factor 2 between 0.89 and 0.95, Factor 3 between 0.63 and 0.83, and Factor 4 between 0.75 and 0.92. In factor-equalization modeling, our model was found to be appropriate since 3 of the confirmatory fit indices were good and 4 of them were acceptable (Table 7).

Table 7.

Confirmatory factor analysis fit indeces.

Index    Good fit  Acceptable  Application  Results 
X2/df  Chi-square/degrees of freedom value  <3  3<(X2/df)<3.302  Acceptable 
RMSEA  Root mean square error of approximation  <0.05  <0.08  0.057  Acceptable 
CFI  Comparative fit index  >0.95  >0.90  0.998  Good fit 
NFI  Fix indeces  >0.95  >0.90  0.998  Good fit 
NNFI (TLI)  Non-normed fix indeces (Tucker-Lewis index)  >0.95  >0.90  0.789  No fit 
IFI  Incremental fit index  >0.95  >0.90  0.998  Good fit 
GFI  Goodness of fit index  >0.90  >0.85  0.849  Acceptable 
AGFI  Adjusted goodness of fit index  >0.90  >0.85  0.854  Acceptable 
Discussion

Health education programs are recommended because of the alarmingly high levels of insufficient information, negative distorted attitudes, and malpractice related to the COVID-19 pandemic in a survey study.18 One study stated that the possibility of control decreases with the increase of transmission of COVID-19 prior to symptoms beginning. It is stated that models are needed to reflect updated transmission characteristics and more specific definitions of epidemic control.19 As states that in these studies, deficiencies in knowledge, education, attitude, behavior, and detecting mistakes are not sufficient in pandemics or other serious situations. These results highlight the importance of scale development in our study. In extraordinary situations such as pandemics, in addition to identifying the situation and problem, there is a need for attitude and behavioral awareness. Our results revealed that positive guidance was provided to individuals to improve attitudes and behaviors in COVID-19 and similar pandemics.

Many adults with comorbid conditions did not have critical knowledge of COVID-19 and did not change their routines or plans despite their concerns. This inequality suggests that more public health efforts may be needed to mobilize the most vulnerable communities.20 More research is needed to prevent the spread of COVID-19 and to evaluate the effectiveness of the measures taken. Responsiveness is crucial to discourage negative health-seeking behaviors and to encourage positive preventive and therapeutic practices for fear of increased mortality.21 In a study in China, participants had good knowledge, positive attitude, and active practice about COVID-19, but the results recommended strengthening nationwide promotion and focus on the uneducated population.22

Situations accompanied by chronic diseases, vulnerable populations, and nationwide decisions suggest the need for a real and reliable identification of the problem, as in these studies. The need for effective scales in these studies also supports the necessity of our study.

Lack of knowledge of appropriate control methods can exacerbate racial and ethnic disparities. Additional research is needed to identify reliable sources of information and disseminate accurate prevention and treatment information.23

It is important to note that additional research is needed after this study, and that methods with a specific scope and content are recommended in research.

Today, younger and healthier populations are affected more than ever before. In the absence of any specific therapeutic agent, such as coronavirus infections, the most effective individual preventative measure is knowledge. This is a time to introspect and learn from our mistakes. Countries need to act urgently in this and similar situations.24

To our knowledge, this scale is the only scale developed regarding knowledge, attitudes and behaviors about COVID-19 in Turkey and in the world. The scale questions in our study will set an example in terms of providing a systematic approach to the problem in COVID-19 and similar pandemics by raising awareness on both physicians and individuals on a scientific basis. The scale will guide the researches during the COVID-19 process and in similar pandemics that may develop thereafter.

Strengths and limitations

To our knowledge, this scale is the first scale developed regarding knowledge, attitudes, and behaviors regarding COVID-19 in Turkey and in the world. The scale will guide researches during the COVID-19 process and in probable future pandemics. This fact will positively contribute to the well-being and health status of people all around the World. Besides these strengths, our study has a limitation of including participants from only one country, namely Turkey. For that reason, it should be developed for other countries by taking into account the health conditions of them, before it can be used as a worldwide scale.

Conclusion

The valid and reliable Turkey COVID-19 Attitude Scale, which we developed to evaluate the knowledge, attitudes and behaviors of individuals about COVID-19, will guide research in the COVID-19 process and future pandemics.

What is known on the topic

  • Since the beginning of the pandemic, studies have been carried out on the information, attitudes and behaviors of individuals and societies against Covid-19. However, the pandemic is not over yet and even tends to increase due to variants.

What this study contributes

  • This scale is the only scale developed regarding knowledge, attitudes and behaviors about COVID-19 in Turkey and in the world. The scale will guide the researches during the COVID-19 process and in similar pandemics that may develop thereafter.

Authors’ contribution

OG, CE conceived, designed, and completed statistical analysis & editing of manuscript.

OG, CE completed data collection and manuscript writing.

OG completed review and final approval of manuscript.

Disclaimer

None.

Source of funding

None.

Conflict of interest

None.

Acknowledgements

We would like to thank Editage (www.editage.com) for English language editing.

References
[1]
E. Mahase.
China coronavirus: WHO declares international emergency as death toll exceeds 200.
BMJ, 368 (2020), pp. m408
[2]
H.V. Fineberg.
Pandemic preparedness and response – lessons from the H1N1 influenza of 2009.
N Engl J Med, 370 (2014), pp. 1335-1342
[3]
K. Ajilore, I. Atakiti, K. Onyenankeya.
College students’ knowledge, attitudes and adherence to public service announcements on Ebola in Nigeria: suggestions for improving future Ebola prevention education programmes.
Health Educ J, 76 (2017), pp. 648-660
[4]
N. Tachfouti, K. Slama, M. Berraho, C. Nejjari.
The impact of knowledge and attitudes on.adherence to tuberculosis teratment: a case–control study in a Moroccan region.
Pan Afr Med J, 12 (2012), pp. 52
[5]
M. Lee, B.-A. Kang, M. You.
Knowledge, attitudes, and practices (KAP) toward COVID-19: a cross-sectional study in South Korea.
BMC Public Health, 21 (2021), pp. 295
[6]
J. Sahar, S.M. Kiik, W. Wiarsih, U. Rachmawati.
Coronavirus disease-19: public health nurses’ knowledge, attitude, practices, and perceived barriers in Indonesia.
Open Access Maced J Med Sci, 8 (2020), pp. 422-428
[7]
Z.F.R. Ladiwala, R.A. Dhillon, Zahid l, O. Irfan, M. Sharjeel Khan, S. Awan, et al.
Knowledge, attitude and perception of Pakistanis towards COVID-19; a large cross-sectional survey.
[8]
B. Yakar, E. Onalan, G. Karakaya, E. Pirincci, R.F. Akkoc, S. Aydın.
Knowledge, behaviours and anxiety of eastern part of Turkey residents about the current COVID-19 outbreak.
Acta Biomed, 92 (2021), pp. e2021179
[9]
K.J. McCaffery, R.H. Dodd, E. Cvejic, J. Ayre, C. Batcup, J.M.J. Isautier, et al.
Health literacy and disparities in COVID-19-related knowledge, attitudes, beliefs and behaviours in Australia.
Public Health Res Pract, 30 (2020), pp. e30342012
[10]
E. Paul, A. Steptoe, D. Fancourt.
Attitudes towards vaccines and intention to vaccinate against COVID-19: implications for public health communications.
Lancet Reg Health Eur, 1 (2021), pp. 100012
[11]
C. Wang, Q. Tian, P. Zhao, M. Xiong, C.A. Latkin, Y. Gan, et al.
Disease knowledge and attitudes during the COVID-19 epidemic among international migrants in China: a national cross-sectional study.
Int J Biol Sci, 16 (2020), pp. 2895-2905
[12]
H. Alıcılar, G. Güneş, M. Çöl.
Toplumda Covid-19 pandemisiyle ilgili farkındalık, tutum ve davranışların değerlendirilmesi.
ESTÜDAM Halk Sağlığı Dergisi, 5 (2020), pp. 1-16
[13]
S. Saadatjoo, M. Miri, S. Hassanipour, H. Ameri, M. Arab-Zozani.
Knowledge, attitudes, and practices of the general population about Coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis with policy recommendations.
Public Health, 194 (2021), pp. 185-195
[14]
A. Alhazmi, M.H.M. Ali, A. Mohieldin, F. Aziz, O.B. Osman, W.A. Ahmed.
Knowledge, attitudes and practices among people in Saudi Arabia regarding COVID-19: a cross-sectional study.
J Public Health Res, 9 (2020), pp. 1867
[15]
S. Sulistyawati, R. Rokhmayanti, B. Aji, S.P.M. Wijayanti, S.K.W. Hastuti, T.W. Sukesi, et al.
Knowledge, attitudes, practices and information needs during the COVID-19 pandemic in Indonesia.
Risk Manage Healthcare Policy, 14 (2021), pp. 163-175
[16]
R. Banik, M. Rahman, M.T. Sikder, Q.M. Rahman, M.U.R. Pranta.
Knowledge, attitudes, and practices related to the COVID-19 pandemic among Bangladeshi youth: a web-based cross-sectional analysis.
Z Gesundh Wiss, (2021), pp. 1-11
[17]
H. Oncel Cekim, C. Kadilar.
ln-type variance estimators in simple random sampling.
Pak J Stat Oper Res, 16 (2020), pp. 689-696
[18]
D. Gebretsadik, S. Gebremichael, M.A. Belete.
Knowledge, attitude and practice toward COVID-19 pandemic among population visiting Dessie Health Center for COVID-19 screening, Northeast Ethiopia.
Infect Drug Resist, 14 (2021), pp. 905-915
[19]
J. Hellewell, S. Abbott, A. Gimma, N.I. Bosse, C.I. Jarvis, T.W. Russell, et al.
Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts.
Lancet Glob Health, 8 (2020), pp. e488-e496
[20]
M.S. Wolf, M. Serper, L. Opsasnick, R.M. O’Conor, L. Curtis, J.Y. Benavente, et al.
Awareness, attitudes, and actions related to COVID-19 among adults with chronic conditions at the onset of the U.S. outbreak: a cross-sectional survey.
Ann Intern Med, 173 (2020), pp. 100-109
[21]
A. Ngwewondo, L. Nkengazong, L.A. Ambe, J.T. Ebogo, F.M. Mba, H.O. Goni, et al.
Knowledge, attitudes, practices of/towards COVID 19 preventive measures and symptoms: a cross-sectional study during the exponential rise of the outbreak in Cameroon.
PLoS Negl Trop Dis, 14 (2020), pp. e0008700
[22]
Y. Fang, P. Liu, Q. Gao.
Assessment of knowledge, attitude, and practice toward COVID-19 in China: an online cross-sectional survey.
Am J Trop Med Hyg, 104 (2021), pp. 1461-1471
[23]
J. Jones, P.S. Sullivan, T.H. Sanchez, J.L. Guest, E.W. Hall, N. Luisi, et al.
Similarities and differences in COVID-19 awareness, concern, and symptoms by race and ethnicity in the United States: cross-sectional survey.
J Med Internet Res, 22 (2020), pp. e20001
[24]
K.K. Sahu, A.K. Mishra, A. Lal.
Trajectory of the COVID-19 pandemic: chasing a moving target.
Ann Transl Med, 8 (2020), pp. 694
Copyright © 2022. The Author(s)
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos